Follow
Belkis Romeu
Title
Cited by
Cited by
Year
Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform
O Pérez, B Romeu, O Cabrera, E González, A Batista-Duharte, A Labrada, ...
Frontiers in immunology 4, 407, 2013
802013
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice
R Acevedo, A Callicó, J Del Campo, E González, B Cedré, L González, ...
Methods 49 (4), 309-315, 2009
432009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses
J Del Campo, C Zayas, B Romeu, R Acevedo, E González, G Bracho, ...
Methods 49 (4), 301-308, 2009
422009
Mucosal approaches in Neisseria vaccinology
J Balboa, B Romeu, M Baró, C Campa, MI Lantero, G Sierra, MA Galindo, ...
VacciMonitor 18 (2), 53-55, 2009
412009
Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii
A Batista-Duharte, M Lastre, B Romeu, DL Portuondo, D Téllez-Martínez, ...
International Immunopharmacology 40, 277-287, 2016
262016
Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non …
B Romeu, M Lastre, L García, B Cedré, A Mandariote, M Fariñas, R Oliva, ...
Immunologic research 58, 75-85, 2014
232014
Meningococcal disease in North America: updates from the global meningococcal initiative
EJ Asturias, X Bai, JA Bettinger, R Borrow, DN Castillo, DA Caugant, ...
Journal of Infection 85 (6), 611-622, 2022
122022
Inmunopotenciadores para la acuicultura
R Pérez, B Romeu, M Lastre, Y Morales, O Cabrera, L Reyes, E González, ...
VacciMonitor 23 (1), 24-31, 2014
122014
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses
B Romeu, E González, C Zayas, JD Campo, R Acevedo, M Cuello, ...
Scandinavian journal of infectious diseases 43 (10), 809-813, 2011
112011
Mucosal and systemic immune responses induced by a single time vaccination strategy in mice
E González Aznar, B Romeu, M Lastre, C Zayas, M Cuello, O Cabrera, ...
Canadian journal of microbiology 61 (8), 531-538, 2015
102015
Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses
B Romeu, M Lastre, L Reyes, E González, Y Borrero, D Lescaille, R Pérez, ...
Vaccine 32 (51), 6971-6978, 2014
102014
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B
C Zayas, D González, R Acevedo, J Del Campo, M Lastre, E González, ...
BMC immunology 14, 1-5, 2013
92013
Mucosal and systemic immune response against Neisseria meningitidis B induced by single time vaccination strategy
N Nuñez, Y Valdez, M Fariñas, O Pérez, E González, B Romeu, ...
VacciMonitor 18 (2), 73-75, 2009
92009
Nasal immunization with AFCo1 induces immune response to N. gonorrhoea in mice
B Romeu, K Thörn, M Lindqvist, J Persson, AM Harandi, O Pérez, ...
Vaccimonitor 18 (2), 76-78, 2009
82009
Adjuvants are key factors for the development of future vaccines: lessons from the finlay adjuvant platform. Front Immunol 4: 407
O Pérez, B Romeu, O Cabrera, E González, A Batista-Duharte, A Labrada, ...
72013
Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1
B Romeu, E Gonzalez, J Del Campo, R Acevedo, C Zayas, Y Valdes, ...
Canadian journal of microbiology 57 (3), 256-261, 2011
72011
Single-time vaccines
OGP Martin, EA Gonzalez, BA Romeu, JMDC Alonso, RG Acevedo, ...
US Patent App. 13/130,146, 2011
52011
Vacunas unitemporales
O Pérez, E González, B Romeu, JM Del Campo, R Acevedo, M Lastre, ...
Cuba patente OCPI: CU20080215 y WO2010057447A1, 2009
52009
Vacunas unitemporales. Patent applied OCPI
O Pérez, E González, B Romeu, J del Campo, R Acevedo, M Lastre
CU/P/2008/215. November 19, 2008
52008
The role of regulatory sciences from the perspective of the Cuban medicines regulatory agency: the impact of COVID-19 in promoting innovation, cooperation and scientific thinking
B Romeu, Y Rodríguez, S Bendiner
Therapeutic Innovation & Regulatory Science 55 (5), 1014-1018, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20